Literature DB >> 24442437

Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway.

Américo Harry López-Yglesias1, Xiaodan Zhao, Ellen K Quarles, Marvin A Lai, Tim VandenBos, Roland K Strong, Kelly D Smith.   

Abstract

Flagellin is a potent immunogen that activates the innate immune system via TLR5 and Naip5/6, and generates strong T and B cell responses. The adaptor protein MyD88 is critical for signaling by TLR5, as well as IL-1Rs and IL-18Rs, major downstream mediators of the Naip5/6 Nlrc4-inflammasome. In this study, we define roles of known flagellin receptors and MyD88 in Ab responses generated toward flagellin. We used mice genetically deficient in flagellin recognition pathways to characterize innate immune components that regulate isotype-specific Ab responses. Using purified flagellin from Salmonella, we dissected the contribution of innate flagellin recognition pathways to promote Ab responses toward flagellin and coadministered OVA in C57BL/6 mice. We demonstrate IgG2c responses toward flagellin were TLR5 and inflammasome dependent; IgG1 was the dominant isotype and partially TLR5 and inflammasome dependent. Our data indicate a substantial flagellin-specific IgG1 response was induced through a TLR5-, inflammasome-, and MyD88-independent pathway. IgA anti-FliC responses were TLR5 and MyD88 dependent and caspase-1 independent. Unlike C57BL/6 mice, flagellin-immunized A/J mice induced codominant IgG1 and IgG2a responses. Furthermore, MyD88-independent, flagellin-induced Ab responses were even more pronounced in A/J MyD88(-/-) mice, and IgA anti-FliC responses were suppressed by MyD88. Flagellin also worked as an adjuvant toward coadministered OVA, but it only promoted IgG1 anti-OVA responses. Our results demonstrate that a novel pathway for flagellin recognition contributes to Ab production. Characterization of this pathway will be useful for understanding immunity to flagellin and the rationale design of flagellin-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24442437      PMCID: PMC3925749          DOI: 10.4049/jimmunol.1301893

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  93 in total

1.  NLRC4 inflammasomes in dendritic cells regulate noncognate effector function by memory CD8⁺ T cells.

Authors:  Andreas Kupz; Greta Guarda; Thomas Gebhardt; Leif E Sander; Kirsty R Short; Dimitri A Diavatopoulos; Odilia L C Wijburg; Hanwei Cao; Jason C Waithman; Weisan Chen; Daniel Fernandez-Ruiz; Paul G Whitney; William R Heath; Roy Curtiss; Jürg Tschopp; Richard A Strugnell; Sammy Bedoui
Journal:  Nat Immunol       Date:  2012-01-08       Impact factor: 25.606

2.  Population variation in NAIP functional copy number confers increased cell death upon Legionella pneumophila infection.

Authors:  Michele Boniotto; Ludovic Tailleux; Mariella Lomma; Brigitte Gicquel; Carmen Buchrieser; Sylvie Garcia; Lluis Quintana-Murci
Journal:  Hum Immunol       Date:  2011-10-23       Impact factor: 2.850

3.  Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity.

Authors:  Mohammad S Hossain; David L Jaye; Brian P Pollack; Alton B Farris; Malefa L Tselanyane; Ebenezer David; John D Roback; Andrew T Gewirtz; Edmund K Waller
Journal:  J Immunol       Date:  2011-10-17       Impact factor: 5.422

4.  The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus.

Authors:  Yue Zhao; Jieling Yang; Jianjin Shi; Yi-Nan Gong; Qiuhe Lu; Hao Xu; Liping Liu; Feng Shao
Journal:  Nature       Date:  2011-09-14       Impact factor: 49.962

Review 5.  Immunological mechanisms of vaccination.

Authors:  Bali Pulendran; Rafi Ahmed
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

Review 6.  Innate responses to Toxoplasma gondii in mice and humans.

Authors:  Reed Pifer; Felix Yarovinsky
Journal:  Trends Parasitol       Date:  2011-09

7.  Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI).

Authors:  David N Taylor; John J Treanor; Cynthia Strout; Casey Johnson; Theresa Fitzgerald; Uma Kavita; Karen Ozer; Lynda Tussey; Alan Shaw
Journal:  Vaccine       Date:  2011-05-17       Impact factor: 3.641

8.  Soluble flagellin, FliC, induces an Ag-specific Th2 response, yet promotes T-bet-regulated Th1 clearance of Salmonella typhimurium infection.

Authors:  Saeeda Bobat; Adriana Flores-Langarica; Jessica Hitchcock; Jennifer L Marshall; Robert A Kingsley; Margaret Goodall; Cristina Gil-Cruz; Karine Serre; Denisse L Leyton; Shirdi E Letran; Fabrina Gaspal; Rebecca Chester; Jayne L Chamberlain; Gordon Dougan; Constantino López-Macías; Ian R Henderson; James Alexander; Ian C M MacLennan; Adam F Cunningham
Journal:  Eur J Immunol       Date:  2011-05-10       Impact factor: 5.532

9.  Innate immune recognition of bacterial ligands by NAIPs determines inflammasome specificity.

Authors:  Eric M Kofoed; Russell E Vance
Journal:  Nature       Date:  2011-08-28       Impact factor: 49.962

Review 10.  Vaccines for the twenty-first century society.

Authors:  Rino Rappuoli; Christian W Mandl; Steven Black; Ennio De Gregorio
Journal:  Nat Rev Immunol       Date:  2011-11-04       Impact factor: 53.106

View more
  29 in total

1.  Dual Immunization with SseB/Flagellin Provides Enhanced Protection against Salmonella Infection Mediated by Circulating Memory Cells.

Authors:  Seung-Joo Lee; Joseph Benoun; Brian S Sheridan; Zachary Fogassy; Oanh Pham; Quynh-Mai Pham; Lynn Puddington; Stephen J McSorley
Journal:  J Immunol       Date:  2017-07-14       Impact factor: 5.422

Review 2.  Proteus spp. as Putative Gastrointestinal Pathogens.

Authors:  Amy L Hamilton; Michael A Kamm; Siew C Ng; Mark Morrison
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

3.  Amino acids 89-96 of Salmonella typhimurium flagellin represent the major domain responsible for TLR5-independent adjuvanticity in the humoral immune response.

Authors:  Lei Zhang; Zhiming Pan; Xilong Kang; Yun Yang; Heekap Kang; Na Zhang; James M Rosati; Xinan Jiao
Journal:  Cell Mol Immunol       Date:  2014-09-08       Impact factor: 11.530

4.  Amino acids 89-96 of Salmonella flagellin: a key site for its adjuvant effect independent of the TLR5 signaling pathway.

Authors:  Xilong Kang; Zhiming Pan; Xinan Jiao
Journal:  Cell Mol Immunol       Date:  2017-11-27       Impact factor: 11.530

Review 5.  An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives.

Authors:  Alessio Facciolà; Giuseppa Visalli; Antonio Laganà; Angela Di Pietro
Journal:  Vaccines (Basel)       Date:  2022-05-22

6.  Activation of NLRC4 downregulates TLR5-mediated antibody immune responses against flagellin.

Authors:  Wei Li; Jingyi Yang; Ejuan Zhang; Maohua Zhong; Yang Xiao; Jie Yu; Dihan Zhou; Yuan Cao; Yi Yang; Yaoming Li; Huimin Yan
Journal:  Cell Mol Immunol       Date:  2015-04-27       Impact factor: 11.530

Review 7.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

8.  The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties.

Authors:  Dorsaf Hedhli; Nathalie Moiré; Haroon Akbar; Fabrice Laurent; Bruno Héraut; Isabelle Dimier-Poisson; Marie Noëlle Mévélec
Journal:  Med Microbiol Immunol       Date:  2016-03-02       Impact factor: 3.402

Review 9.  Linking genetic variation in human Toll-like receptor 5 genes to the gut microbiome's potential to cause inflammation.

Authors:  Cynthia A Leifer; Cameron McConkey; Sha Li; Benoit Chassaing; Andrew T Gewirtz; Ruth E Ley
Journal:  Immunol Lett       Date:  2014-10-02       Impact factor: 3.685

10.  CD103+CD11b+ mucosal classical dendritic cells initiate long-term switched antibody responses to flagellin.

Authors:  A Flores-Langarica; K Müller Luda; E K Persson; C N Cook; S Bobat; J L Marshall; M W Dahlgren; K Hägerbrand; K M Toellner; M D Goodall; D R Withers; I R Henderson; B Johansson Lindbom; A F Cunningham; W W Agace
Journal:  Mucosal Immunol       Date:  2017-12-20       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.